Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
for
Long Haul COVID, Postural Orthostatic Tachycardia Syndrome
Location: Bethesda MD
Sponsor: Uniformed Services University of the Health Sciences
Sex: All
Age: 18 - 70+
Code: NCT05481177
Recruiting
Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep
for
Sleep Deprivation, Mental Competency
Location: Bethesda MD
Sponsor: U.S. Army Medical Research and Development Command
Sex: All
Age: 18 - 39
Code: NCT02945501
Recruiting
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT07619547
Recruiting
New
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
for
Recurrent Small Cell Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07509034
Phase1, Recruiting
New
Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 10 - 17
Code: NCT07566468
Recruiting
New
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
for
Breast Cancer, Breast Carcinoma, Cancer of the Breast,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07619534
Recruiting
New
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
B-All, Acute Lymphoblastic Leukemia
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT07572136
Phase1, Recruiting
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)